ArticleFrontiers in public health2025
Analysis of COVID-19 reinfection and its influencing factors among primary healthcare workers in Jiangsu Province: a study based on the omicron variant epidemic.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Subsequent SARS-CoV-2 Infection in Healthcare Workers: A Retrospective Cohort Study in Iran.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Since the global outbreak of SARS-CoV-2 in 2019, COVID-19 reinfection has become an increasing concern, particularly during the spread of the Omicron variant. Despite numerous international studies on COVID-19 reinfection, research focusing on healthcare workers, particularly those in primary care settings in mainland China, remains limited. This study aims to evaluate COVID-19 reinfection rates among primary healthcare workers (PHWs) in Jiangsu Province and to explore potential risk factors contributing to reinfection. Methods: This study utilized a combination of online questionnaires and on-site surveys to conduct two waves of investigation targeting PHWs after epidemic control policy adjustment in Jiangsu Province. Differences between the infection at the baseline visit and re-infection at the follow-up visit were analyzed, and multivariate logistic regression was used to assess the factors influencing reinfection. Results: A total of 5,541 PHWs were included in the study. At the baseline visit, the initial infection rate was 85.85% [95% confidence interval (CI): 84.93-86.77%], and the self-reported reinfection rate was 40.05% (95% CI: 38.65-41.44%). After adjustment, the reinfection rate was 29.41% (95% CI: 28.12-30.71%). The median reinfection interval between the two infections was 146 days (Interquartile range: 129-164 days). Logistic regression model revealed that female sex [odds ratio (OR) = 1.376, 95% CI: 1.190-1.592], history of fever clinic work (OR = 1.179, 95% CI: 1.045-1.330), working over 8 h per day (OR = 1.178, 95% CI: 1.040-1.336), being a nurse (OR = 1.201, 95% CI: 1.029-1.402), and a "less meat, more vegetables" diet (OR = 1.206, 95% CI: 1.020-1.426) were significant risk factors for reinfection. Additionally, regular physical exercise was found to be a protective factor (OR = 0.861, 95% CI: 0.754-0.983). Conclusion: COVID-19 reinfection rates were relatively high among PHWs in Jiangsu Province, particularly among women, nurses, those with fever clinic experience and working over 8 h per day. This study offers valuable insights for the prevention of COVID-19 reinfection and the development of protection strategies for PHWs. It is recommended that more targeted protective measures be implemented for high-risk groups, including appropriate work arrangements, regular health monitoring, and the promotion of healthy lifestyle habits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.